Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Caliway Biopharmaceuticals Completes U.S. FDA IND Submission for Phase 2 Study of CBL-514 in Weight Management, Targeting Combination with GLP-1RA Therapies
Thursday, December 25, 2025Caliway Biopharmaceuticals has completed its US FDA IND submission for a Phase clinical trial of CBL combined with GLPRA therapies to address weight rebound and improve body composition in weight management
Zai Lab receives China approval for COBENFY, a first-in-class treatment for schizophrenia
Wednesday, December 24, 2025Zai Lab Limited has received approval from Chinas National Medical Products Administration NMPA for the New Drug Application of COBENFY xanomeline and trospium chloride to treat adults with schizophrenia
Meiji Seika Pharma Establishes Meiji Pharma Asia Pte. Ltd. in Singapore to Bolster ASEAN Pharma Presence
Tuesday, December 23, 2025Meiji Seika Pharma has established a whollyowned subsidiary in Singapore to enhance commercialization marketing and distribution of pharmaceuticals including vaccines across the ASEAN region
Merck Receives Approval for Pimicotinib in Rare Joint Tumour Tenosynovial Giant Cell Tumour (TGCT)
Tuesday, December 23, 2025Merck has secured the worlds first regulatory approval for pimicotinib as a systemic treatment for adults with symptomatic tenosynovial giant cell tumour TGCT in China
AstraZeneca and Daiichi Sankyo’s Enhertu Receives Breakthrough Therapy Designation for Early HER2-Positive Breast Cancer
Tuesday, December 23, 2025AstraZeneca and Daiichi Sankyos Enhertu trastuzumab deruxtecan has been granted Breakthrough Therapy Designation by the US Food and Drug Administration FDA for use as a postneoadjuvant treatment in adults
Rectify and Boehringer Ingelheim Partner to Develop New Treatments for Chronic Kidney Disease
Tuesday, December 23, 2025Rectify Pharmaceuticals has entered into a strategic research and licensing collaboration with Boehringer Ingelheim to support the development of new treatments for chronic kidney disease CKD and related conditions
Boehringer Ingelheim Receives Approval for JASCAYD® in Progressive Pulmonary Fibrosis
Monday, December 22, 2025Boehringer Ingelheim has received approval from the US Food and Drug Administration FDA for JASCAYD nerandomilast tablets for the treatment of progressive pulmonary fibrosis PPF in adults
Cryoport Systems Named Finalist in Four Categories at Asia-Pacific Biopharma Excellence Awards 2026
Friday, December 19, 2025Cryoport Systems has been named a finalist in four categories for the AsiaPacific Biopharma Excellence Awards highlighting its innovation in biopharma supply chain solutions
Celltrion receives positive CHMP opinion for SteQeyma autoinjector
Friday, December 19, 2025Celltrion has received a positive opinion from the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA for the autoinjector version of SteQeyma a biosimilar to Stelara ustekinumab
Galux signs research agreement with Boehringer Ingelheim to advance AI-based protein design
Friday, December 19, 2025Galux a South Koreabased biotechnology company focused on AIdriven protein therapeutics discovery has entered into a research agreement with Boehringer Ingelheim The collaboration aims to explore
